Mesoblast (MESO) Tax Rate Growth (1y) (2018 - 2023)

Mesoblast (MESO) Tax Rate Growth (1y) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Mesoblast 2.01 Bn 1.87 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -6.00
Mar 31, 2023 4.00
Dec 31, 2022 -2.00
Sep 30, 2022 5.00
Jun 30, 2022 -5.00
Mar 31, 2022 -16.00
Dec 31, 2021 60.00
Sep 30, 2021 -262.00
Jun 30, 2021 -879.00
Mar 31, 2021 -1,099.00
Dec 31, 2020 -874.00
Sep 30, 2020 -2,316.00
Jun 30, 2020 -421.00
Mar 31, 2020 324.00
Dec 31, 2019 -198.00
Sep 30, 2019 2,253.00
Jun 30, 2019 862.00
Mar 31, 2019 -583.00
Dec 31, 2018 -23,173.00